datamatters24/research-document-archive huggingface dataset:
HR 5664 RFS
plications denied during the previous calendar year 
with respect to which the basis for such denial, in-
cluded grounds related to human trafficking (as 
such term is defined in section 103 of the Traf-
ficking Victims Protection Act of 2000 (22 U.S.C. 
7102) (as amended by section 5(b))). 
(b) ANNUAL REPORT.—Beginning with the first an-
nual anti-trafficking report required under subsection 
(b)(1) of section 110 of the Trafficking Victims Protection 
Act of 2000 (22 U.S.C. 7107; enacted as division A of 
the Victims of Trafficking and Violence Protection Act of 
2000) that is submitted after the date of the enactment 
of this Act and concurrent with each such subsequent sub-
mission for the following seven years, the Secretary of 
State shall submit to the relevant congressional commit-
tees a report that contains information relating to the 
number and the locations of United States visa denials 
based, in whole or in part, on grounds related to human 
trafficking (as such term is defined in section 103 of the 
Trafficking Victims Protection Act of 2000 (22 U.S.C. 
7102) (as amended by section 5(b))) during the period 
covered by each such annual anti-trafficking report. 
SEC. 7. DEFINITIONS. 
In this Act: 
VerDate Sep 11 2014 
18:09 Sep 24, 2020
Jkt 099200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H5664.RFS
H5664
pamtmann on DSKBC07HB2PROD with BILLS
HR 5664 RFS
(1) LOCATIONS OF UNITED STATES VISA DENI-
ALS.—The term ‘‘location of United States visa de-
nials’’ means— 
(A) the United States diplomatic or con-
sular post at which a denied United States visa 
application was adjudicated; and 
(B) the city or locality of residence of the 
applicant whose visa application was so denied. 
(2) 
RELEVANT
CONGRESSIONAL
COMMIT-
TEES.—The term ‘‘relevant congressional commit-
tees’’ means— 
(A) the Committee on Foreign Affairs and 
the Committee on the Judiciary of the House of 
Representatives; and 
(B) the Committee on Foreign Relations 
and the Committee on the Judiciary of the Sen-
ate. 
Passed the House of Representatives September 22, 
2020. 
Attest: 
CHERYL L. JOHNSON, 
Clerk. 
VerDate Sep 11 2014 
18:09 Sep 24, 2020
Jkt 099200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H5664.RFS
H5664
pamtmann on DSKBC07HB2PROD with BILLS
I 
116TH CONGRESS 
2D SESSION 
H. R. 5682 
To amend title 38, United States Code, to furnish hospital care and medical 
services to veterans, members of the reserve components of the Armed 
Forces, and dependents who were stationed at Wurtsmith Air Force 
Base in Oscoda, Michigan, and were exposed to volatile organic com-
pounds, to provide for a presumption of service connection for those 
veterans and members of the reserve components, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 27, 2020 
Mr. KILDEE introduced the following bill; which was referred to the 
Committee on Veterans’ Affairs 
A BILL 
To amend title 38, United States Code, to furnish hospital 
care and medical services to veterans, members of the 
reserve components of the Armed Forces, and dependents 
who were stationed at Wurtsmith Air Force Base in 
Oscoda, Michigan, and were exposed to volatile organic 
compounds, to provide for a presumption of service con-
nection for those veterans and members of the reserve 
components, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
00:25 Jan 28, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5682.IH
H5682
kjohnson on DSK79L0C42PROD with BILLS
I 
116TH CONGRESS 
2D SESSION 
H. R. 5668 
To amend the Federal Food, Drug, and Cosmetic Act to modernize the 
labeling of certain generic drugs, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 24, 2020 
Ms. MATSUI (for herself and Mr. GUTHRIE) introduced the following bill; 
which was referred to the Committee on Energy and Commerce 
A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
modernize the labeling of certain generic drugs, and for 
other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Making Objective Drug 
Evidence Revisions for New Labeling Act of 2020’’ or the 
‘‘MODERN Labeling Act of 2020’’. 
VerDate Sep 11 2014 
23:42 Jan 24, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5668.IH
H5668
kjohnson on DSK79L0C42PROD with BILLS
SEC. 2. MODERNIZING THE LABELING OF CERTAIN GE-
NERIC DRUGS. 
Chapter V of the Federal Food, Drug, and Cosmetic 
Act (21 U.S.C. 351 et seq.) is amended by inserting after 
section 503C the following: 
‘‘SEC. 503D. PROCESS TO UPDATE LABELING FOR CERTAIN 
DRUGS. 
‘‘(a) DEFINITIONS.—For purposes of this section: 
‘‘(1) The term ‘covered drug’ means a drug ap-
proved under section 505(c)— 
‘‘(A) for which there are no unexpired pat-
ents included in the list under section 505(j)(7) 
and no unexpired period of exclusivity; 
‘‘(B) for which the approval of the applica-
tion has been withdrawn for reasons other than 
safety or effectiveness; and 
‘‘(C) for which, with respect to the label-
ing— 
‘‘(i) new scientific evidence is available 
regarding the conditions of use of the 
drug; 
‘‘(ii) there is a relevant accepted use 
in clinical practice that is not reflected in 
the approved labeling; or 
VerDate Sep 11 2014 
23:42 Jan 24, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5668.IH
H5668
kjohnson on DSK79L0C42PROD with BILLS
‘‘(iii) the labeling of such drug does 
not reflect current legal and regulatory re-
quirements. 
‘‘(2) The term ‘period of exclusivity’, with re-
spect to a drug approved under section 505(c), 
means any period of exclusivity under clause (ii), 
(iii), or (iv) of section 505(c)(3)(E), clause (ii), (iii), 
or (iv) of section 505(j)(5)(F), or section 505A, 
505E, or 527. 
‘‘(3) The term ‘generic version’ means a drug 
approved under section 505(j) whose reference drug 
is a covered drug. 
‘‘(4) The term ‘relevant accepted use’ means a 
use for a drug in clinical practice that is supported 
by scientific evidence that appears to the Secretary 
to meet the standards for approval under section 
505. 
‘‘(5) The term ‘selected drug’ means a covered 
drug for which the Secretary has determined 
through the process under subsection (c) that the la-
beling should be changed. 
‘‘(b) IDENTIFICATION
OF COVERED DRUGS.—The 
Secretary may identify covered drugs for which labeling 
updates would provide a public health benefit. To assist 
VerDate Sep 11 2014 
23:42 Jan 24, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5668.IH
H5668
kjohnson on DSK79L0C42PROD with BILLS
(2) STAKEHOLDER OUTREACH.—Not later than 
180 days after the date of the enactment of this Act, 
the Administrator of the Transportation Security 
Administration (TSA) shall conduct outreach to rel-
evant stakeholders described in paragraph (1)(D) 
that regularly are granted access to Sensitive Secu-
rity Information to raise awareness of the TSA’s 
policies and guidelines governing the designation and 
use of Sensitive Security Information. 
(b) INTERNATIONAL AVIATION SECURITY.— 
(1) IN GENERAL.—Not later than 60 days after 
the date of the enactment of this Act, the Adminis-
trator of the Transportation Security Administration 
shall develop and implement guidelines with respect 
to last point of departure airports to— 
(A) ensure the inclusion, as appropriate, of 
air carriers and other transportation security 
stakeholders in the development and implemen-
tation of security directives and emergency 
amendments; 
(B) document input provided by air car-
riers and other transportation security stake-
holders during the security directive and emer-
gency amendment, development, and implemen-
tation processes; 
VerDate Sep 11 2014 
23:42 Jan 24, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5670.IH
H5670
kjohnson on DSK79L0C42PROD with BILLS
legal effect for the applicant that is different than the 
legal effect that would have resulted if a supplemental 
application had been submitted and approved to con-
form the labeling of the generic version to a change 
in the labeling of the reference drug. 
‘‘(2) SUPPLEMENTAL APPLICATIONS.—Changes to 
labeling made in accordance with this section shall 
not be eligible for an exclusivity period under this 
Act. 
‘‘(3) SELECTION
OF
DRUGS.—Nothing in this 
section shall be construed to give the Secretary the au-
thority to identify a drug as a covered drug or select 
a drug label for updating solely based on the avail-
ability of new safety information. Upon identification 
of a drug as a covered drug, the Secretary may then 
consider the availability of new, additional, or dif-
ferent safety information in determining whether the 
drug is a selected drug and in determining what la-
beling changes are appropriate. 
‘‘(4) MAINTENANCE OF LABELING.—Nothing in 
this section shall be construed to affect the responsi-
bility of the holder of an approved application under 
section 505(j) to maintain its labeling in accordance 
with existing requirements, including subpart B of 
part 201 and sections 314.70 and 314.97 of title 21, 
VerDate Sep 11 2014 
01:13 Nov 17, 2020
Jkt 019200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6203
E:\BILLS\H5668.RH
H5668
pamtmann on DSKBC07HB2PROD with BILLS
116TH CONGRESS 
2D SESSION 
H. R. 5671 
AN ACT 
To award a Congressional Gold Medal, collectively, 
to the United States Merchant Mariners of 
World War II, in recognition of their dedicated 
and vital service during World War II.
Code of Federal Regulations (or any successor regula-
tions). 
‘‘(i) RULES OF CONSTRUCTION.— 
‘‘(1) APPROVAL STANDARDS.—This section shall 
not be construed as altering the applicability of the 
standards for approval of an application under sec-
tion 505. No order shall be issued under this sub-
section unless the scientific evidence supporting the 
changed labeling meets the standards for approval ap-
plicable to any change to labeling under section 505. 
‘‘(2) SECRETARY AUTHORITY.—Nothing in this 
section shall be construed to limit the authority of the 
Secretary to require labeling changes under section 
505(o). 
‘‘(j) REPORTS.—Not later than 4 years after the date 
of the enactment of the Making Objective Drug Evidence 
Revisions for New Labeling Act of 2020, and every 4 years 
thereafter, the Secretary shall prepare and submit to the 
Committee on Energy and Commerce of the House of Rep-
resentatives and the Committee on Health, Education, 
Labor, and Pensions of the Senate, a report that— 
‘‘(1) describes the actions of the Secretary under 
this section, including— 
‘‘(A) the number of covered drugs and de-
scription of the types of drugs the Secretary has 
VerDate Sep 11 2014 
01:13 Nov 17, 2020
Jkt 019200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6203
E:\BILLS\H5668.RH
H5668
pamtmann on DSKBC07HB2PROD with BILLS
selected for labeling changes and the rationale for 
such recommended changes; and 
‘‘(B) the number of times the Secretary en-
tered into discussions concerning a disagreement 
with an application holder or holders and a 
summary of the decision regarding a labeling 
change, if any; and 
‘‘(2) includes any recommendations of the Sec-
retary for modifying the program under this sec-
tion.’’. 
VerDate Sep 11 2014 
01:13 Nov 17, 2020
Jkt 019200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6203
E:\BILLS\H5668.RH
H5668
pamtmann on DSKBC07HB2PROD with BILLS
Union Calendar No. 471 
116TH CONGRESS 
2D SESSION 
H. R. 5668 
[Report No. 116–573] 
A BILL 
To amend the Federal Food, Drug, and Cosmetic 
Act to modernize the labeling of certain generic 
drugs, and for other purposes. 
NOVEMBER 16, 2020 
Reported with an amendment; committed to the Com-
mittee of the Whole House on the State of the Union 
and ordered to be printed 
VerDate Sep 11 2014 
01:13 Nov 17, 2020
Jkt 019200
PO 00000
Frm 00012
Fmt 6651
Sfmt 6651
E:\BILLS\H5668.RH
H5668
pamtmann on DSKBC07HB2PROD with BILLS
I 
116TH CONGRESS 
2D SESSION 
H. R. 5669 
To require the Administrator of the Small Business Administration to estab-
lish a program to assist small business concerns with purchasing cyberse-
curity products and services, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 24, 2020 
Ms. FINKENAUER (for herself and Mr. JOYCE of Pennsylvania) introduced the 
following bill; which was referred to the Committee on Small Business 
A BILL 
To require the Administrator of the Small Business Adminis-
tration to establish a program to assist small business 
concerns with purchasing cybersecurity products and 
services, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Strengthening and En-
hancing Cybersecurity Usage to Reach Every Small Busi-
ness Act’’ or the ‘‘SECURE Small Business Act’’. 
VerDate Sep 11 2014 
23:42 Jan 24, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5669.IH
H5669
kjohnson on DSK79L0C42PROD with BILLS
SEC. 2. CYBERSECURITY COOPERATIVE MARKETPLACE 
PROGRAM. 
(a) ESTABLISHMENT.—Not later than 180 days after 
the date of the enactment of this Act, the Administrator 
of the Small Business Administration, in consultation with 
the Director of the National Institute of Standards and 
Technology, shall establish a program to assist small busi-
ness concerns with purchasing cybersecurity products and 
services. 
(b) DUTIES.—In the program established under sub-
section (a), the Administrator shall do the following: 
(1) Educate small business concerns about the 
types of cybersecurity products and services that are 
specific to each covered industry sector. 
(2) Provide outreach to covered vendors and 
small business concerns to encourage use of the co-
operative marketplace described in subsection (c). 
(c) COOPERATIVE MARKETPLACE FOR PURCHASING 
CYBERSECURITY PRODUCTS
AND SERVICES.—The Ad-
ministrator shall— 
(1) establish and maintain a website that— 
(A) is free to use for small business con-
cerns and covered vendors; and 
(B) provides a cooperative marketplace 
that facilitates the creation of mutual agree-
ments under which small business concerns co-
VerDate Sep 11 2014 
23:42 Jan 24, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5669.IH
H5669
kjohnson on DSK79L0C42PROD with BILLS
trator of the Transportation Security Administration 
(TSA) shall— 
(A) ensure clear and consistent designation 
of ‘‘Sensitive Security Information’’, including 
reasonable security justifications for such des-
ignation; 
(B) develop and implement a schedule to 
regularly review and update, as necessary, TSA 
Sensitive Security Information Identification 
guidelines; 
(C) develop a tracking mechanism for all 
Sensitive Security Information redaction and 
designation challenges; 
(D) document justifications for changes in 
position regarding Sensitive Security Informa-
tion redactions and designations, and make 
such changes accessible to TSA personnel for 
use with relevant stakeholders, including air 
carriers, airport operators, surface transpor-
tation operators, and State and local law en-
forcement, as necessary; and 
(E) ensure that TSA personnel are ade-
quately trained on appropriate designation poli-
cies. 
VerDate Sep 11 2014 
23:42 Jan 24, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H5670.IH
H5670
kjohnson on DSK79L0C42PROD with BILLS
operatively purchase cybersecurity products and 
services from covered vendors; and 
(2) determine whether each covered vendor and 
each small business concern that participates in the 
marketplace described in this subsection is legiti-
mate, as determined by the Administrator. 
(d) SUNSET.—This section ceases to be effective on 
September 30, 2024. 
SEC. 3. GAO STUDY ON AVAILABLE FEDERAL CYBERSECU-
RITY INITIATIVES. 
(a) IN GENERAL.—The Comptroller General of the 
United States shall conduct a study that identifies any im-
provements that could be made to Federal initiatives 
that— 
(1) train small business concerns how to avoid 
cybersecurity threats; and 
(2) are in effect on the date on which the 
Comptroller General commences the study. 
(b) REPORT.—Not later than 1 year after the date 
of the enactment of this Act, the Comptroller General shall 
submit to the Committee on Small Business and Entrepre-
neurship of the Senate and the Committee on Small Busi-
ness of the House of Representatives a report that con-
tains the results of the study required under subsection 
(a). 
VerDate Sep 11 2014 
23:42 Jan 24, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H5669.IH
H5669
kjohnson on DSK79L0C42PROD with BILLS
SEC. 4. DEFINITIONS. 
In this Act: 
(1) ADMINISTRATOR.—The term ‘‘Adminis-
trator’’ means the Administrator of the Small Busi-
ness Administration. 
(2) COVERED
INDUSTRY
SECTOR.—The term 
‘‘covered industry sector’’ means the following indus-
try sectors: 
(A) Accommodation and food services. 
(B) Agriculture. 
(C) Construction. 
(D) Healthcare and social assistance. 
(E) Retail and wholesale trade. 
(F) Transportation and warehousing. 
(G) Entertainment and recreation. 
(H) Finance and insurance. 
(I) Manufacturing. 
(J) Information and telecommunications. 
(K) Any other industry sector the Adminis-
trator determines to be relevant. 
(3) COVERED
VENDOR.—The term ‘‘covered 
vendor’’ means a vendor of cybersecurity products 
and services, including cybersecurity risk insurance. 
(4) CYBERSECURITY.—The term ‘‘cybersecu-
rity’’ means— 
VerDate Sep 11 2014 
23:42 Jan 24, 2020
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5669.IH
H5669
kjohnson on DSK79L0C42PROD with BILLS
(A) the art of protecting networks, devices, 
and data from unauthorized access or criminal 
use; and 
(B) the practice of ensuring confidentiality, 
integrity, and availability of information. 
(5) CYBERSECURITY THREAT.—The term ‘‘cy-
bersecurity threat’’ means the possibility of a mali-
cious attempt to infiltrate, damage, disrupt, or de-
stroy computer networks or systems. 
(6) SMALL
BUSINESS
CONCERN.—The term 
‘‘small business concern’’ has the meaning given 
under section 3(a) of the Small Business Act (15 
U.S.C. 632(a)). 
Æ 
VerDate Sep 11 2014 
23:42 Jan 24, 2020
Jkt 099200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\H5669.IH
H5669
kjohnson on DSK79L0C42PROD with BILLS
I 
116TH CONGRESS 
1ST SESSION 
H. R. 566 
To amend title 38, United States Code, to remove the manifestation period 
required for the presumptions of service connection for chloracne, 
porphyria cutanea tarda, and acute and subacute peripheral neuropathy 
associated with exposure to certain herbicide agents. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 15, 2019 
Mr. COURTNEY (for himself, Mr. YOUNG, and Mr. LARSON of Connecticut) 
introduced the following bill; which was referred to the Committee on 
Veterans’ Affairs 
A BILL 
To amend title 38, United States Code, to remove the mani-
festation period required for the presumptions of service 
connection for chloracne, porphyria cutanea tarda, and 
acute and subacute peripheral neuropathy associated 
with exposure to certain herbicide agents. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Agent Orange Expo-
sure Fairness Act’’. 
VerDate Sep 11 2014 
03:25 Jan 29, 2019
Jkt 089200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H566.IH
H566
kjohnson on DSK79L0C42 with BILLS
SEC. 2. REMOVAL OF MANIFESTATION PERIOD REQUIRED 
FOR PRESUMPTIONS OF SERVICE CONNEC-
TION FOR CERTAIN DISEASES ASSOCIATED 
WITH EXPOSURE TO CERTAIN HERBICIDE 
AGENTS. 
Section 1116(a)(2) of title 38, United States Code, 
is amended— 
(1) in subparagraph (C), by striking ‘‘within 
one’’ and all that follows through ‘‘1975’’; 
(2) in subparagraph (E), by striking ‘‘within a’’ 
and all that follows through ‘‘1975’’; and 
(3) by adding at the end the following new sub-
paragraph: 
‘‘(I) Acute and subacute peripheral neuropathy 
becoming manifest to a degree of disability of 10 
percent or more.’’. 
Æ 
VerDate Sep 11 2014 
03:25 Jan 29, 2019
Jkt 089200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H566.IH
H566
kjohnson on DSK79L0C42 with BILLS
I 
116TH CONGRESS 
2D SESSION 
H. R. 5670 
To improve the understanding and clarity of Transportation Security 
Administration policies, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JANUARY 24, 2020 
Mr. BISHOP of North Carolina introduced the following bill; which was 
referred to the Committee on Homeland Security 
A BILL 
To improve the understanding and clarity of Transportation 
Security Administration policies, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Transportation Secu-
rity Transparency Improvement Act’’. 
SEC. 
2. 
SENSITIVE 
SECURITY 
INFORMATION; 
INTER-
NATIONAL AVIATION SECURITY. 
(a) SENSITIVE SECURITY INFORMATION.— 
(1) IN GENERAL.—Not later than 90 days after 
the date of the enactment of this Act, the Adminis-
VerDate Sep 11 2014 
23:42 Jan 24, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H5670.IH
H5670
kjohnson on DSK79L0C42PROD with BILLS
(C) define a process, including time 
frames, and with the inclusion of feedback from 
air carriers and other transportation security 
stakeholders, for cancelling or incorporating se-
curity directives and emergency amendments 
into security programs; 
(D) conduct engagement with foreign part-
ners on the implementation of security direc-
tives and emergency amendments, as appro-
priate, including recognition if existing security 
measures at a last point of departure airport 
are found to provide commensurate security as 
intended by potential new security directives 
and emergency amendments; and 
(E) ensure that new security directives and 
emergency amendments are focused on defined 
security outcomes. 
(2) BRIEFING TO CONGRESS.—Not later than 
90 days after the date of the enactment of this Act, 
the Administrator of the Transportation Security 
Administration shall brief the Committee on Home-
land Security of the House of Representatives and 
the Committee on Commerce, Science, and Trans-
portation of the Senate on the guidelines described 
in paragraph (1). 
VerDate Sep 11 2014 
20:16 Jan 27, 2020
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H5670.IH
H5670
kjohnson on DSK79L0C42PROD with BILLS
(3) DECISIONS NOT SUBJECT TO JUDICIAL RE-
VIEW.—Notwithstanding any other provision of law, 
any action of the Administrator of the Transpor-
tation Security Administration under paragraph (1) 
is not subject to judicial review. 
Æ 
VerDate Sep 11 2014 
23:42 Jan 24, 2020
Jkt 099200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\H5670.IH
H5670
kjohnson on DSK79L0C42PROD with BILLS